Investing.com - IVERIC bio (NASDAQ: ISEE) reported first quarter EPS of $-0.470, $0.10 worse than the analyst estimate of $-0.370. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.
IVERIC bio's stock price closed at $20.780. It is down -9.890% in the last 3 months and up 55.840% in the last 12 months.
IVERIC bio saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See IVERIC bio's stock price’s past reactions to earnings here.
According to InvestingPro, IVERIC bio's Financial Health score is "weak performance".
Check out IVERIC bio's recent earnings performance, and IVERIC bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar